ArticleThe European respiratory journal2022
"Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension." Mark Toshner, Colin Church, Lars Harbaum,
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.